BIOCURE TECHNOLOGY INC. (1WH) — Strategic Asset Allocation Index
BIOCURE TECHNOLOGY INC. (1WH) has a Strategic Asset Allocation Index of 124.7% as of December 2025. Strategic assets (PP&E of €- plus long-term investments of €1.97 Million) total €1.97 Million, measured against net assets of €1.58 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BIOCURE TECHNOLOGY INC. balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
BIOCURE TECHNOLOGY INC. Strategic Asset Allocation Index (2023–2025)
This chart shows how BIOCURE TECHNOLOGY INC.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the index stands at 124.7%, representing strategic assets of €1.97 Million against net assets of €1.58 Million EUR. For live market cap and overall valuation, see BIOCURE TECHNOLOGY INC. (1WH) market capitalisation.
Annual Strategic Asset Allocation Index for BIOCURE TECHNOLOGY INC. (2023–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for BIOCURE TECHNOLOGY INC. from 2023 to 2025, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See BIOCURE TECHNOLOGY INC. (1WH) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 124.7% | €1.97 Million | €- | €1.97 Million | €1.58 Million | ▼ -21.9 pp |
| 2024 | 146.6% | €1.97 Million | €- | €1.97 Million | €1.34 Million | ▲ +24.0 pp |
| 2023 | 122.6% | €1.97 Million | €- | €1.97 Million | €1.60 Million | — |